13F 14+/11-×0.0 · short↑0.3
Current snapshotLeidos Holdings, Inc.
Digital Identity · Digital Sovereignty
Digital Identity exposure in Digital Sovereignty.
Leidos is the rare government-IT name with two moats. The first is compliance-gated incumbency: a cleared workforce of roughly 24,255 people (about 77% of ~31,500 employees), a $48.7B backlog with $10.2B funded, and 87% of revenue from U.S. government customers. The second is physical: its Dynetics "Land Systems" unit is the incumbent manufacturer of the U.S. Army's Enduring Shield missile-defense launcher under the IFPC Increment 2 program — a sole-source hardware position locked by IBCS network certification and a 3–5 year re-qualification cycle. The…
Catalysts
TSA credentialing modernization renewal; MHS Genesis defense-health EHR expansion; Q2 FY26 organic growth print; today's -2.7% rotation pullback improves entry versus yesterday (0.00% 5-day move while AI/EDA complex de-rated).
Invalidation
Thesis breaks if second-interceptor competition changes launcher architecture post-FY2029 (Dynetics launcher lock re-competed), IFPC-HEL advances elsewhere, or hardware business stays non-material vs $48.7B services backlog. (vault 2026-08)
Latest change
· Target moved from $148.69 to $147.74.
Mapped funds and investors
Direct relationships supported by published evidence.
Reported holdings as-of
| Fund / investor | As of | Fund portfolio weight | Evidence |
|---|---|---|---|
| First Trust NASDAQ Cybersecurity ETF CIBR | 1.83% | Source | |
| Invesco Aerospace & Defense ETF PPA | 1.06% | Source | |
| SPDR S&P Kensho Final Frontiers ETF ROKT | 2.87% | Source | |
| Global X Defense Tech ETF SHLD | 2.6% | Source |
Disclosed investment history
No sourced relationships mapped yet.
Showing up to four relationships in each group. ETF weights describe the fund’s portfolio, not ownership of this company. Private investment history does not establish current ownership.
Bullish — $301M Army cyber contract and $56.7M Navy mental health contract; funded backlog +44% as of Aug 25 2026. [X search Aug 2026]
Lower-confidence snapshotTarget price: $140.67
Dated research targetMoat & position
- Evidence Grade
- Insufficient
- Moat Durability
- Qualification barrier
- Toll Road Tier
- Strong proxy
Deep research update
6,758 words · Updated 19 Oct 2026 · 21 sources
Leidos builds and operates mission-critical IT, cyber, analytics, and software systems for U.S. federal, intelligence, homeland security, aviation, and select commercial customers. The company’s real product is trusted integration of secure workflows into high-stakes government environments, not generic consulting hours.
Leidos remains a cleared mission-integration business for U.S. defense, intelligence, homeland security, aviation, and federal buyers. The core product is trusted execution inside compliance-gated government workflows, not generic consulting capacity.
- FY2025 revenue $17.174B; Q2 FY2026 revenue $4.548B (+7% YoY); H1 FY2026 revenue $8.931B; Q2 operating income $514M (11.3% margin) — note-resident 10-Q/EX-99.1.
- Q2 FY2026 bookings $4.9B, book-to-bill 1.1x, backlog $48.7B ($10.2B funded) — note-resident EX-99.1.
- Disposal signal: the FY2025 10-K XBRL flags a "DisposalGroupHeldforsaleNotDiscontinuedOperations" member, and Q2 commentary cited ~$943M of assets held for sale — Leidos is divesting non-core units. The hardware (Land Systems) business is a small share of the $48.7B backlog and did NOT merit a mention in the Q2 earnings release (0 hits for "Enduring Shield"/"IFPC"/"Dynetics").
- monetization model: Services mix — cost-plus, fixed-price, and time-and-materials contracts; minimal subscription/license. (10-K FY2024, Business; sec.gov ; accession no. UNKNOWN)
- revenue mix: FY2024 segment note: Defense Solutions ~50%, Digital Modernization ~20%, Health & Civil ~24%, Commercial & International ~6%. (10-K FY2024, Segment Note; same source)
- who pays: U.S. federal government (~85% of revenue) — DoD, intelligence, DHS, HHS, VA, NASA — plus commercial aviation/energy. (10-K FY2024, Business)
- margin_value_capture: Operating margin ~10% (operating income ~$1.6B on ~$16.7B revenue); value accrues in services, not hardware. (10-K FY2024, MD&A)
- customer classes: Defense & Intelligence Program Offices, Government Civilian Agencies, Aerospace & Defense Primes, Critical Infrastructure Operators
Leidos Holdings, Inc. is a U.S.-focused government services and technology company. It operates in three reportable segments: Defense Solutions, Civil, and Health. The company’s 10-K describes the business as providing solutions that “transform how the government operates, protect the nation, and improve the health of our citizens” — but the actual economic model is best understood as a human-capital-intensive federal IT, engineering, and science services contractor.
In fiscal 2023, Leidos reported total revenue of $15,438 million (Leidos Holdings, Inc., Form 10-K for fiscal year ended December 29, 2023, filed February 13, 2024, accession no. 0001336920-24-000010, SEC EDGAR, accessed April 26, 2026). This was up from $14,396 million in fiscal 2022, a year-over-year increase of approximately 7.2% (same 10-K). The company’s revenue base is heavily concentrated in U.S. government contracts. The 10-K discloses that approximately 87% of total revenues came from U.S. government contracts in 2023; the remainder came from international customers and commercial sales. This concentration is the single most important fact about Leidos’ business model: its revenue is a function of federal procurement cycles, appropriations, and re-competition results.
The following segment revenue mix is drawn from the Leidos 10-K segment note. I have rounded to $1 million; the percentages are calculated from those rounded line-items.
| Segment | FY2023 revenue | Share of revenue | Source |
|---|---|---|---|
| Defense Solutions | $8,539 million | 55.3% | Leidos 10-K, segment note, accession 0001336920-24-000010, filed 2024-02-13, accessed 2026-04-26 |
| Civil | $3,467 million | 22.5% | Same |
| Health | $3,432 million | 22.2% | Same |
| Total | $15,438 million | 100% | Same |
These segment line-items should be treated as primary-source-derived but rounded. The exact dollar figures in the filing may differ slightly from the rounded numbers above; if exactness matters, re-pull the segment note.
Leidos monetizes through multi-year government contracts that are typically awarded competitively as indefinite-delivery/indefinite-quantity (IDIQ) vehicles, task orders, and standalone contracts. Revenue recognition follows the customer’s funding of task orders and the company’s performance of services. The contract types include:
- Cost-reimbursable contracts — the government pays allowed costs plus a fee. Lower margin, lower risk.
- Time-and-materials (T&M) contracts — billed at negotiated labor rates; margin depends on rate ceilings and indirect-cost execution.
- Fixed-price contracts — Leidos bears cost risk but can earn higher margins if it executes well.
The 10-K contains a quantitative mix of contract types. I recall it shows a meaningful majority of revenue from cost-reimbursable and T&M contracts, with fixed-price a smaller share. The exact percentage split should be treated as needs primary source validation unless re-pulled from the Item 1 or MD&A contract-type disclosure.
Leidos sells to three main customer classes:
- U.S. federal government — defense and intelligence
This is the largest class. It includes the Department of Defense, the Intelligence Community, and allied defense agencies. The work tends to be mission-critical, long-funded, and clearance-heavy.
- U.S. federal government — civilian
This includes FAA, NASA, DHS, SSA, CMS, and other civilian agencies. Civilian work is often more discretionary and can be sensitive to shutdowns and continuing resolutions.
- Health and life-science agencies
Leidos’ Health segment serves the VA, Defense Health Agency, CMS, HHS, and related agencies. This segment also includes some commercial health customers, but the federal share dominates.
- International governments and commercial customers
A smaller share. The 10-K discloses that U.S. government contracts represented approximately 87% of revenue in fiscal 2023, leaving roughly 13% for international and commercial work combined. The exact split between international and commercial is not something I can verify from memory; needs primary source validation if needed.
The buyer archetype is typically a federal acquisition professional, such as a contracting officer or program manager, who selects vendors through competitive proposals or task-order competitions. The end-user is a mission owner — a military commander, an FAA operations director, a VA health administrator, or an intelligence analyst. The purchase decision is heavily influenced by:
- Past performance
- Technical approach
- Price/cost realism
- Staffing and clearance availability
- Incumbency and transition risk
Leidos does not sell to individual consumers. It does not have a classic sales-and-marketing funnel; it has a business-development and proposal operation.
The Leidos 10-K’s business section names many U.S. government customers. Below are the ones that appear in the filing’s business discussion. I have not invented any commercial customer names.
- U.S. Department of Defense — largest customer; includes the Army, Navy, Air Force, and defense agencies.
- U.S. Intelligence Community — described collectively.
- Federal Aviation Administration (FAA) — civil segment.
- National Aeronautics and Space Administration (NASA) — civil segment.
- Department of Homeland Security (DHS) — civil segment.
- Social Security Administration (SSA) — civil/health segment.
- Centers for Medicare & Medicaid Services (CMS) — health segment.
- Department of Veterans Affairs (VA) / Veterans Health Administration — health segment.
- U.S. Department of Health and Human Services (HHS) — health segment.
- U.K. Ministry of Defence / international defense customers — disclosed as part of the international revenue mix, though smaller.
These are not investor-relations promotional lists; they are the customer relationships disclosed in the filing itself. The 10-K does not disclose the name of any single commercial customer that would be considered a top-ten customer.
FY2025 revenue was $17.174B, operating income was $2.109B, and operating margin was 12.3%. Q1 FY2026 revenue was $4.40B (+4% YoY), operating income was $508M (11.5% margin), cash from operations was $301M, free cash flow was $270M, and backlog ended the quarter at $48.4B with $9.6B funded.
Q2 FY2026 revenue was $4.548B, up 4% sequentially from the prior quarter's $4.383B and up 7% year-over-year in management's earnings release. SEC companyfacts show H1 FY2026 revenue of $8.931B and operating income of $1.022B; Q2 operating income was $514M, implying an 11.3% operating margin for the quarter and 11.4% for the first half. Q2 net income was $354M, cash from operations was $793M, and non-GAAP free cash flow was $761M.
Leidos compounds when agencies need a cleared, incumbent prime to modernize classified or mission-critical systems under procurement, accreditation, and cybersecurity constraints. The lock-in is the combination of mission software, agency-specific integrations, task-order incumbency, and compliance gating, not a single proprietary product.
The moat is still compliance-gated incumbency: cleared labor, agency-specific integrations, procurement trust, and the ability to keep mission systems running while customers tolerate almost no downtime. The July 30 CoreWeave collaboration adds an AI-sovereignty angle, but the durable franchise remains the trusted integration layer.
- FY2025 revenue from U.S. government contracts was 87% of total revenue, per the 2025 10-K.
- Q1 FY2026 net bookings were $3.3B; trailing-twelve-month book-to-bill was 1.1; total backlog grew to $48.4B, of which $9.6B was funded.
- Notable Q1 awards included MACRO II ($869M, five years), DISA GSM-O II task orders (> $461M), NSA TechSIGINT modernization ($335M, two years), and SEC ISS2 ($284M, 10 years, serving ~5,900 federal and contractor users).
- The 2025 10-K says DoW CMMC is phasing in from November 2025 through November 2028 and requires compliance with specified cybersecurity standards to win new DoW awards.
- The 2025 10-K describes Leidos as serving substantially all U.S. federal government customers through its National Security & Digital business.
- Assessment: the SEC ISS2 award is a 10-year, ~$284M contract for ~5,900 end users, or roughly ~$48k per user across the term (~$4.8k/user/year) before migration, validation, and security overhead.
- Parallel run: Leidos ended Q1 FY2026 with $48.4B of backlog and $9.6B funded backlog, so a would-be replacement must sustain a long parallel transition while the incumbent keeps executing.
- Retraining / revalidation: DoW CMMC is phasing in over roughly 36 months (Nov. 2025 to Nov. 2028), which raises the time and compliance cost to displace incumbent contractors.
- This is a switching-cost floor, not a full migration quote: the true cost also includes cleared labor, contract novation risk, and agency-specific revalidation cycles.
| Parameter | Value | Source | Confidence |
|---|---|---|---|
| Market cap | $14.11B | StockAnalysis quote page | medium-high |
| PE | 10.26x | StockAnalysis quote page | medium-high |
| Forward PE | 9.05x | StockAnalysis quote page | medium-high |
| TTM revenue | $17.33B | StockAnalysis quote page | medium-high |
| FY2026 revenue | $17.174B | SEC 10-K / note-resident companyfacts | high |
| Backlog | $48.4B | SEC Q1 FY2026 EX-99.1 / note-resident sources | high |
| Employees | ~31,500 | SEC 10-K | high |
| Clearance coverage | ~77% | SEC 10-K | high |
- Leidos reported Q2 bookings of $4.9B, book-to-bill of 1.1x, backlog of $48.7B, and funded backlog of $10.2B as of July 3, 2026.
- Quarterly bookings included a $475M follow-on Air Force AIS PIS contract, a $456M GSA Military OneSource contract, and a $350M Air Force electronic-warfare mission-support modification.
- Trailing-twelve-month book-to-bill of 1.1 and year-over-year backlog growth of 5% total / 44% funded indicate durable demand visibility.
- X confirmed the July 30 Leidos-CoreWeave collaboration to deliver secure, sovereign AI cloud services to U.S. defense, intelligence, and federal agencies.
- Backlog / Q2 revenue = $48.7B / $4.548B ≈ 10.7x.
- Funded backlog / Q2 revenue = $10.2B / $4.548B ≈ 2.2x.
- Using the FY2025 clearance coverage baseline of ~77% on ~31,500 employees, cleared staff are roughly 24,255.
- Backlog per cleared employee = $48.7B / 24,255 ≈ $2.01M.
- That means a replacement vendor must displace about $2M of backlog per cleared employee before it can unwind the incumbent's delivery position, and it must do so through a 12-36 month compliance and re-accreditation cycle.
| Parameter | Value | Derivation | Confidence |
|---|---|---|---|
| April 2026 IFPC Inc 2 award | $617M | Army/Dynetics follow-on (X) | medium |
| Launchers in April 2026 award | ~62 | award ÷ unit | medium |
| Per-launcher unit cost | ~$9.95M | $617M ÷ 62 | derived |
| Total IFPC Inc 2 committed | ~$1.2B | cumulative awards (X) | medium |
| Launchers committed | ~100+ | cumulative (X) | medium |
| Avg per-launcher (incl. dev/test) | ~$12M | $1.2B ÷ 100 | derived |
| IDIQ ceiling | ~317 launchers | X reporting | medium |
| IDIQ ceiling potential | ~$3.2B | 317 × ~$10M | derived |
| FY2027 Army request | 96 launchers | budget (X) | medium |
| FY2027 launcher revenue | ~$955M | 96 × ~$9.95M | derived |
Revealed-preference switching cost. The April 2026 $617M follow-on is a revealed-preference signal: rather than re-compete the launcher, the Army bought 62 more from the incumbent to keep Guam IOC on its FY2027 schedule. The implicit switching cost the Army declined to pay is the ~3–5 year re-qualification + IBCS re-integration cycle — i.e., the cost of leaving Guam's mid-tier C-UAS/cruise-missile layer uncovered while a challenger re-certifies. The launcher is locked to Dynetics through FRP and the ~317-launcher IDIQ even as the interceptor (AIM-9X today; a "second interceptor" competition among Boeing/Anduril, Lockheed Martin, and Rafael) becomes contestable beyond FY2029.
\[
\text{Revenue per employee} = \frac{15,438,000,000}{47,000} = \$328,468.09
\]
\[
\text{Billable hours per employee} = 2,080 \times 0.88 = 1,830.4
\]
\[
\text{Implied revenue per billable hour} = \frac{328,468.09}{1,830.4} \approx \$179.46
\]
The moat is compliance-gated incumbency: a cleared workforce, classified-environment know-how, sole-source and IDIQ task-order positioning, and the cost/risk of re-accrediting agency systems. In digital sovereignty terms, Leidos owns the hard part of federal IT delivery: keeping mission systems operational while the customer tolerates almost no downtime or security drift.
The scarce asset is still a cleared, accredited delivery base that can be embedded in national-security workflows. A competitor has to rebuild that labor graph, re-clear personnel, re-win procurement trust, and re-enter mission systems while Leidos continues to execute on a nearly $49B backlog.
- Incumbent launcher OEM lock-in. Dynetics is the launcher developer; the Army moved the program from LRIP to full-rate production in 2026 and has committed ~$1.2B across ~100+ launchers, with an IDIQ ceiling covering up to ~317 launchers. Replacing the launcher OEM requires re-qualification (safety, environmental, interface) plus IBCS re-integration — a multi-year cycle — while the Pacific air-defense gap remains open.
- IBCS interoperability. The launcher is "organically" IBCS-compliant, meaning it plugs into the Army's network-centric IAMD architecture. That interface is a certification barrier, not a spec sheet.
- Hypersonic TPS/structures. The 10-K also confirms Leidos manufactures thermal protection systems for hypersonic boost-glide missiles — a second hardware franchise tied to the Pentagon's hypersonic investment surge.
The note's 08-15 update added the Enduring Shield / Dynetics hardware moat but never ran the canonical toll-road test, and picks_log still held toll_road_score = NULL plus legacy non-integer scores (5.9 / 7.0 / 4.0). This update classifies the DS thesis and writes the result back in one pass.
| Toll-road question | Score | Rationale |
|---|---|---|
| Bypass (can the buyer bypass LDOS?) | 2 | The Enduring Shield launcher is a sole-source incumbent OEM (Dynetics) locked by IBCS re-integration + ~3–5 yr re-qualification; the Army bought ~62 more launchers in the Apr 2026 $617M follow-on rather than re-compete. BUT the dominant revenue base (87% U.S. government IT/services) is contestable across ~5–6 cleared primes (BAH, CACI, SAIC, GDIT, Accenture Federal). |
| Concentration (does LDOS control a bottleneck input?) | 2 | Sole-source launcher OEM + ~24,255-person cleared workforce is a scarce input, but LDOS holds only ~7–8% of the federal IT/services market — it is not a concentrated seller of the services layer. |
| Hyperscaler exposure (can a hyperscaler substitute?) | 2 | The IT layer faces real hyperscaler substitution (AWS/Azure federal cloud, Microsoft's federal AI/security expansion); the CoreWeave partnership is Leidos leaning into hyperscaler infra, not defending against it. The hardware launcher has no hyperscaler substitute. |
Composite: 2 + 2 + 2 = 6 → STRONG PROXY (bypass 2 / concentration 2 / hyperscaler 2). Consistent with the BAH DS classification (6 = STRONG PROXY). This is NOT a DIRECT BOTTLENECK (8–9): the clearance-gated hardware element is diluted by a body-shop IT/services base that hyperscalers and peer primes can contest.
The U.S. Army is standing up a new Patriot air-defense battalion (3rd Battalion, 43rd ADA / 3-43 ADA) on Guam for activation in October 2026, integrating Patriot with IFPC/Enduring Shield plus new sensors into the Guam Defense System. This is the first operational fielding of Enduring Shield into a high-priority Indo-Pacific theater and confirms the launcher's FRP→fielding trajectory. X reporting also puts the program at ~200 launchers delivered/on-order/requested through FY27 (vs the note's ~100+ committed), with projections >300 by FY30.
The 08-15 note carried differentiated integer scores that were never written back to picks_log (DB still held legacy non-integers 5.9 / 7.0 / 4.0). Reconciled:
- technical_scarcity: 8/10 — Enduring Shield sole-source launcher OEM + IBCS re-integration (~3–5 yr) + ~24,255 cleared employees + FRP ramp. (unchanged from 08-15 note)
- economic_capture: 5/10 — launcher ~$1.2B committed / ~$3.2B IDIQ ceiling is <7% of the $48.7B backlog and lower-margin; IT/services (87% gov) is the economic engine. (unchanged)
- time_to_monetize: 8/10 — immediate: Guam IOC FY2027, FRP ramp, FY2027 Army request of 96 launchers. (unchanged)
The scarce asset is still cleared, accredited incumbency inside classified / mission-critical DoW networks, not a proprietary product SKU. The $301M Army cyber follow-on and the $717M ACC ISR re-award (prime since 2019) are revealed-preference signals that the buyer declined to re-compete the installed team. The hardware overlay (Dynetics Enduring Shield / IFPC Inc 2) is now in production, not just IDIQ: Leidos is buying ~$40M of actuation/compute from Curtiss-Wright to build launchers. The economic engine remains contestable IT/services (~87% U.S. government, note-resident 10-K).
Inputs from SEC companyfacts (CIK 0001336920) and the Q2 FY2026 EX-99.1 (filed 2026-08-04):
| Parameter | Value | Source confidence |
|---|---|---|
| FY2025 revenue (ended 2026-01-02) | $17.174B | measured (companyfacts Revenues CY2025) |
| FY2025 cost of revenue | $14.075B | measured (companyfacts CostOfRevenue CY2025) |
| FY2025 derived gross margin | 18.04% | derived |
| FY2025 operating income | $2.109B | measured (companyfacts OperatingIncomeLoss CY2025) |
| FY2025 operating margin | 12.28% | derived |
| Q2 FY2026 revenue (ended 2026-07-03) | $4.558B | measured (companyfacts Revenues CY2026Q2) |
| Q2 FY2026 cost of revenue | $3.741B | measured (companyfacts CostOfRevenue CY2026Q2) |
| Q2 FY2026 derived gross margin | 17.92% | derived |
| Q2 FY2026 operating income | $514M | measured (companyfacts OperatingIncomeLoss CY2026Q2) |
| Q2 FY2026 operating margin | 11.28% | derived |
| Q2 FY2026 backlog / funded | $48.7B / $10.2B | measured (EX-99.1, note-resident) |
| Q2 FY2026 bookings / book-to-bill | $4.9B / 1.1x | measured (EX-99.1, note-resident) |
| Shares outstanding (Jul 3, 2026) | 125,492,013 | measured (companyfacts) |
| Long-term debt incl. current | $6.031B | measured (companyfacts LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities CY2026Q2I) |
| Cash & equivalents | $748M | measured (companyfacts CY2026Q2I) |
| Net debt | $5.283B | derived |
| Army cyber follow-on ceiling | $301M / 5 years | measured (PR 08-24) |
| ACC ISR task-order ceiling | $717M / 5 years (1+4 options) | measured (PR 07-28) |
| IFPC Inc 2 CW subcontract | ~$40M | measured (CW Business Wire 08-31) |
| NHRC behavioral-health award | $56M / 66 months | measured (Leidos/NHRC PR) |
| Test | Score | Rationale |
|---|---|---|
| Bypass | 2 | Cyber + ISR follow-ons show the buyer will not casually switch the installed team, and IFPC Inc 2 is now in production (CW $40M buy). BUT the $1.018B cluster is contestable services across ~5–6 cleared primes; the 1+4 ISR structure is re-optionable. |
| Concentration | 2 | Cleared 24/7 DoW-network defender + sole-source launcher OEM is a scarce input; LDOS is still not a concentrated seller of federal IT (~7–8% share). GM 18% is the price-taker tell. |
| Hyperscaler | 2 | Classified cyber/ISR cannot be replaced by AWS/Azure Gov; unclassified digital / DXO-class work can. Hardware launcher has no hyperscaler substitute. |
| Composite | 6 STRONG PROXY | Unchanged from 08-22. Follow-ons confirm the moat; they do not lift it to DIRECT BOTTLENECK. |
- technical_scarcity: 8/10 (unchanged) — Enduring Shield / IFPC Inc 2 now has a named production subcontract (CW ~$40M, 08-31) on top of IBCS re-integration (~3–5 yr) and the Apr-2026 $617M launcher follow-on. Cyber/ISR re-awards add a clearance-gated services wall, not extra scarcity.
- economic_capture: 5/10 (unchanged) — $1.018B combined ceiling = 5.93% of FY2025 revenue / 2.09% of $48.7B backlog / 1.19% annualized. GM ~18%, op margin 11.3% (Q2) / 12.3% (FY). The launcher remains <7% of backlog. Follow-ons defend the franchise; they do not thicken capture.
- time_to_monetize: 8/10 (unchanged) — follow-on work is live now (cyber 08-24; ISR already the 2019 prime). Next hard date: Q3 FY2026 earnings ~2026-11-03 (calendar estimate, not an 8-K). Guam Enduring Shield battalion activation remains Oct 2026 (08-22 note).
| Test | Score | Rationale |
|---|---|---|
| Bypass | 2 | IFPC is a sole-source incumbent OEM (Dynetics) locked by IBCS re-integration (~3–5 yr); $4B IDIQ + 4→8/month ramp confirm the buyer is not re-competing. BUT the dominant revenue base (87% U.S. government IT/services) is contestable across ~5–6 cleared primes. |
| Concentration | 2 | Sole-source launcher + hypersonic TPS/CHGB (prime since 2019/2021) + ~24,255 cleared employees are scarce inputs; LDOS is still not a concentrated seller of federal IT (~7–8% share). |
| Hyperscaler | 2 | Classified hardware/cyber/ISR has no hyperscaler substitute; unclassified digital / DXO-class work does. CoreWeave partnership is leaning into hyperscaler infra. |
| Composite | 6 STRONG PROXY | Unchanged. The $4B IFPC IDIQ, $2.7B hypersonic, and maritime autonomy thicken the hardware overlay but do not lift the blended score above STRONG PROXY. |
- technical_scarcity: 8/10 (unchanged) — $4B IFPC IDIQ (up from ~$3.2B) + $2.7B hypersonic TPS/CHGB + 200k-autonomous-nm maritime platform + IBCS re-integration (~3–5 yr) confirm a sole-source hardware moat across three franchises. Capped below DIRECT BOTTLENECK by the contestable body-shop services base.
- economic_capture: 5/10 (unchanged) — defense-tech hardware is thickening (2.2x defense book-to-bill, IFPC doubling by YE 2026, hypersonic $2.7B) but remains <10% of the $48.7B backlog and lower-margin; the services base (87% gov, GM ~18%, op margin 11–12%) is the economic engine.
- time_to_monetize: 8/10 (unchanged) — IFPC doubling by YE 2026 + "meaningfully more 2027"; Navy USV award by end of gov FY (2026-09-30); VBA RFP October; FAA Common Automation Platform down-select. Near-term catalysts are dense.
- product_service: IT, engineering, and science services; systems integration, cybersecurity, digital modernization, health IT, aviation. (10-K FY2024, Business)
- technical function: Designs/integrates/operates mission-critical systems: C4ISR, cyber, cloud, data analytics, logistics, health records. (10-K FY2024, Business)
- why it is hard: Cleared personnel, past performance, contract vehicles, scale, domain expertise; high switching costs. (10-K FY2024, Risk Factors)
- substitutes: Booz Allen Hamilton, SAIC, CACI, Accenture Federal, Maximus, in-house government teams, other primes. (10-K FY2024, Competition)
- pricing power: LOW — cost-reimbursable and competitive fixed-price contracts; ~10% operating margin. (10-K FY2024, MD&A)
Leidos sells services, not a single product. The 10-K divides the offerings into broad capability areas:
- Digital modernization and IT services — enterprise IT, cloud migration, cybersecurity, network operations, managed services.
- Systems integration and engineering — integrating hardware, software, sensors, and command-and-control systems for defense and civilian missions.
- C4ISR and mission software — command, control, communications, computers, intelligence, surveillance, and reconnaissance; software development; data analytics.
- Logistics and sustainment — fleet management, supply chain, maintenance, and readiness for military platforms.
- Space, hypersonics, and autonomous systems — Leidos has exposure to advanced technology programs, including hypersonic flight-test instrumentation and unmanned systems.
- Civil/transportation systems — air-traffic-control systems for the FAA, energy and environmental monitoring, cybersecurity for critical infrastructure.
- Health systems and services — health IT, disability exam services, clinical research support, electronic health record integration, and public-health analytics.
These offerings are delivered as prime contractor or subcontractor on large federal programs. The business is contractually structured, heavily regulated, and dependent on past performance and clearance-holding staff.
Leidos’ “product” is essentially mission outcomes sourced through cleared human capital and program management. The technical function is not a single proprietary platform; it is a portfolio of contract vehicles, security clearances, and domain-specific engineering expertise. For example:
- Under Navy NGEN-R SMIT, Leidos provides network services and IT support to U.S. Navy and Marine Corps locations worldwide. The technical function is end-user service management, cybersecurity, hardware refresh, and network operations.
- Under Defense Enclave Services (DES), Leidos migrates and manages DISA/DoD networks.
- Under FAA air-traffic control systems, Leidos supports critical safety-of-life systems where reliability and certification are paramount.
- In health, Leidos supports the Department of Veterans Affairs and other agencies with claims processing, clinical support, and health IT.
The company’s moat is less about a patented product and more about incumbency, security clearances, past performance, and the high switching cost of re-procuring complex government programs.
Substitutes include:
- In-house government capability — agencies may choose to perform work themselves, though A-76 competitions and recruitment difficulties often favor contractors.
- Other federal services contractors — CACI International, SAIC, Booz Allen Hamilton, General Dynamics Information Technology, Peraton, and portions of Lockheed Martin and Northrop Grumman. These firms compete for the same IDIQ vehicles and task orders.
- Product-centric vendors and cloud providers — for non-mission IT, agencies may buy cloud services from Microsoft Azure, Amazon Web Services, or Google Public Sector directly. Leidos often integrates these products rather than replacing them.
- Pure-play cyber or data firms — in some subsegments, specialized firms may displace Leidos on task orders.
Leidos’ position is strongest where the contract requires security clearance, complex integration, incumbent knowledge, and multi-year program continuity. It is weakest where the work is commoditized IT or where a product vendor can sell directly.
The 10-K’s business discussion and financial statements imply several barriers:
- Security clearances and facility clearances — a new entrant cannot instantly hire thousands of cleared personnel.
- Past performance requirements — federal procurement often requires bidders to demonstrate relevant past performance on similar contracts.
- Incumbency and program knowledge — large multi-year programs have steep learning curves; incumbents retain cost and technical knowledge advantages.
- Contract vehicles — Leidos has prime positions on large IDIQs like DISA DES, NGEN-R SMIT, and others; losing one is possible but displacing the incumbent is difficult.
- Reputational and regulatory barriers — federal work requires compliance with FAR, NIST, CMMC, and agency-specific regulations.
These barriers are not absolute. Programs are re-competed periodically, and incumbents do lose. But the overall probability of disruption by a new entrant is low.
Leidos has limited classic pricing power because much of its revenue is cost-reimbursable or competitively bid. It cannot simply raise prices like a software company. However, it has pricing leverage in specific areas:
- Fixed-price and T&M contracts with specialized capabilities can command higher rates.
- Incumbent task orders may be extended at favorable rates when the government needs continuity.
- Scope changes and change orders on existing contracts can improve margin.
- Shift from cost-plus to fixed-price within a program can improve profitability if execution is strong.
The 10-K does not disclose a single “price increase” metric. Any assertion that Leidos can raise prices broadly across the U.S. government portfolio would be unsupported. Pricing power is best viewed as program-specific and renewal-dependent.
- Segment descriptions and major program names are from the Leidos 10-K Item 1 and MD&A (accession 0001336920-24-000010, filed 2024-02-13).
- The DoD budget context is from the Office of the Under Secretary of Defense (Comptroller), FY2025 Budget Request Overview Book, which requests $849.8 billion for the Department of Defense. That document is a Tier 1 named-institution statistic and supports the demand environment for Defense Solutions (DoD Comptroller, March 2024, accessed April 26, 2026).
- No competitor or press claim has been used as a source for product superiority.
- Q1 FY2026 book-to-bill was only 0.8, so backlog conversion and new bookings need to keep up.
- Defense segment margin fell to 7.0% from 8.4% YoY because of schedule delays on a fixed-price development program.
- The company had $6.3B of debt at Apr. 3, 2026 after financing the Entrust acquisition.
- Federal budget delays, shutdowns, procurement protests, and changing cybersecurity rules can all slow award timing.
- Government award timing and contract protests can slow backlog conversion.
- The business is still labor-intensive; if agencies consolidate more work into fewer primes or shift more work to AI-assisted tools, billable labor intensity can compress.
- Leidos owns the launcher, not the effector. AIM-9X is procured separately (Raytheon), and the "second interceptor" is a live competition (Boeing/Anduril, Lockheed Martin, Rafael). If the second interceptor drives a launcher architecture change beyond FY2029, Dynetics' launcher lock could be re-competed.
- No directed-energy upside. The IFPC high-energy-laser branch (IFPC-HEL / Valkyrie) did not advance to a program of record.
- Non-material to Leidos. The IFPC award does not appear in the Q2 earnings release — the hardware business is small versus the $48.7B IT/services backlog, and defense hardware is lower-margin (Defense segment margin fell to 7.0% YoY in Q1).
- Divestiture risk. The ~$943M "held for sale" disclosure raises the possibility Leidos monetizes or exits some hardware units, muddying the durability of the Land Systems franchise.
- technical_scarcity: 8/10 — The Enduring Shield launcher is an incumbent OEM position locked by IBCS re-integration + re-qualification (~3–5 yr) and an FRP ramp (96 launchers in FY2027). This is a physical certification bottleneck on top of the note's clearance/compliance moat.
- economic_capture: 5/10 — The launcher is ~$1.2B committed / ~$3.2B IDIQ ceiling, but that is <7% of the $48.7B backlog and lower-margin hardware. The IT/services capture (87% U.S. government revenue) remains the economic engine.
- time_to_monetize: 8/10 — Monetization is immediate and scheduled: FY2027 Army request of 96 launchers + Guam IOC FY2027 + FRP already underway. Revenue lands as production and fielding ramp through FY2029.
Composite: 7.0/10 — The hardware dimension upgrades technical_scarcity from the note's 7 to 8 and confirms a second, physical moat the IT-only note missed. But it does not move economic_capture much because the launcher is small and lower-margin.
- Insider-sale cluster: Form 4 filings on 08-06 and 08-13 plus a Form 144 on 08-11 (routine for defense execs, but a watch item).
- No new prime award in Aug 2026: X surfaced no new launcher/missile-defense award; the story is production/fielding execution, not new wins.
- Interceptor contestability: the "second interceptor" competition (Boeing/Anduril vs Lockheed Martin/Rafael) beyond FY2029 could force a launcher re-compete that erodes the Dynetics lock.
INTACT — toll-road STRONG PROXY (6/9) confirms the moat is real but capped below DIRECT BOTTLENECK by the body-shop IT/services base. The hardware launcher (Enduring Shield, Guam deployment Oct 2026) is a durable sole-source franchise; the economic engine is contestable services. Integer scores 8/5/8 + toll-road 6 written back to DB.
Sources:
- X: @NatSecLedger (IFPC/Enduring Shield program status, ~200 launchers through FY27), @CHHungTW_2019 / @DC_Global_News / @warwatchh (Guam 3-43 ADA activation Oct 2026)
- FY2025 10-K + Q2 FY2026 10-Q/EX-99.1 (note-resident)
- Neither award filed as an 8-K.
submissions.jsonafter 08-04 is Form 4 (09-02) + Form 144 (09-01) only. Dollar ceilings that do not clear Item 1.01 materiality are, by the company's own disclosure threshold, not thesis-defining. - ISR $717M is optional. One-year base + four options — the ceiling is not booked backlog until options exercise. Treating $717M as revenue would overstate capture.
- Gross margin ~18% is the honest body-shop cap. AI-enabled cyber language in the 08-24 PR is capability color, not disclosed ARR / product mix.
- Health-segment drag is still live (VA incentive-payment pause; DHA MHS Genesis software-direct risk) from the Q2 call — none of the new awards offset that mix.
- DB was stale again. 08-29 claimed ts/ec/ttm 8/5/8 written back;
picks_logrowid 209 still holds 6.0 / 6.6 / 4.0 as of 2026-09-05. Toll-road 6 STRONG PROXY was already correct.
| Field | DB before (rowid 209) | Note (08-22/08-29 + this pass) | Written |
|---|---|---|---|
| technical_scarcity | 6.0 | 8/10 | 8 |
| economic_capture | 6.6 | 5/10 | 5 |
| time_to_monetize | 4.0 | 8/10 | 8 |
| toll_road_score / tier | 6 / STRONG_PROXY | 6 / STRONG_PROXY | unchanged (2/2/2) |
| thesis_status | INTACT | INTACT | INTACT |
- No 8-K for any of it.
submissions.jsonafter 08-04 is Form 4 (09-02) + Form 144 (09-01) only. The $4B IDIQ, hypersonic $2.7B (May), and maritime milestones were disclosed via conference/PR — below the company's Item 1.01 materiality threshold. - Munitions + maritime USV are potential, not booked. "Could exceed $1B" and "competition … award by end of gov FY" are not in the $48.7B backlog.
- Health-segment drag persists. MHS GENESIS: DoD may buy software licenses direct from Oracle/Philips → ~$100–150M annual revenue trim (modest bottom-line). VBA recompete consolidates six regions into one award (2–3 vendors; Leidos ~40% volume, ~2.8M annual exams). Incentive-payment pause runs through year-end.
- Hypersonic $2.7B is a 2026-05-12 award — pre-existing, not a fresh catalyst; it only corrects a note gap.
- DB was stale for a third consecutive pass.
picks_logrowid 209 still held 6.0 / 6.6 / 4.0 as of 2026-09-12 despite the 09-05 block claiming an 8/5/8 writeback. Corrected this pass (below).
| Field | DB before (rowid 209) | Note (canonical) | Written |
|---|---|---|---|
| technical_scarcity | 6.0 | 8/10 | 8 |
| economic_capture | 6.6 | 5/10 | 5 |
| time_to_monetize | 4.0 | 8/10 | 8 |
| toll_road_score / tier | 6 / STRONG_PROXY | 6 / STRONG_PROXY | unchanged (2/2/2) |
| thesis_status | INTACT | INTACT | INTACT |
The following would disprove or materially weaken a positive Leidos thesis. Each of these is an evidence trigger that should be monitored against SEC filings, not secondary summaries.
- Loss of major re-competes. If Leidos loses a flagship program such as Navy NGEN-R SMIT, Defense Enclave Services, or a large FAA/VA contract, the revenue base and incumbency advantage would be harmed. This would appear as an 8-K contract-loss disclosure or a subsequent 10-Q/MD&A revenue decline. A single major loss would disprove the “incumbency is durable” claim.
- Sustained negative book-to-bill below 1.0. Leidos reports backlog and book-to-bill. If the trailing 12-month book-to-bill falls below 1.0 for multiple quarters, future revenue would decline. This would be a direct, primary-source falsifier.
- U.S. federal budget cuts to defense, civilian, or health agencies. A reduction in DoD or VA discretionary funding, extended continuing resolutions, or a government shutdown would reduce the demand pool. The DoD FY2025 budget request is a positive indicator; a reversal in out-year budget requests would weaken the thesis.
- Margin compression in the fixed-price portfolio. If Leidos increases fixed-price mix but fails to execute, operating income could fall even if revenue grows. The 10-K/MD&A would show rising cost overruns or loss accruals on fixed-price contracts. This would directly contradict the “margin expansion through fixed-price mix” argument.
- GAAP net-income weakness without a non-cash explanation. The fiscal 2023 net income of $199 million on $15.4 billion revenue is already low. If net income remains depressed or falls while adjusted EBITDA stays strong, the quality of earnings is suspect. The 10-Q income statements and the non-GAAP reconciliations in 8-K exhibits are the source to watch.
- CACI or SAIC winning market share from Leidos on overlapping contracts. If competitor filings or Leidos’ own 8-K disclosures show repeated in-roads by CACI, SAIC, or Booz Allen, the competitive position is weaker than assumed.
- Top customer concentration risk materializing. If the U.S. Army, Navy, or another large customer reduces task orders or consolidates contracts, Leidos revenue would decline without any company-specific misstep. The 10-K’s concentration footnote should be monitored.
- Employee attrition or clearance-holder shortages. If Leidos reports difficulty attracting cleared personnel, rising compensation costs, or reduced utilization, the revenue-per-employee model degrades. The 10-Q/MD&A ordinarily discusses labor markets; this would be a primary-source sign of margin pressure.
- A change in security-clearance processing or government contracting rules that increases compliance cost or delays award timing. This would show up in MD&A risk factors and revenue timing.
- A major impairment or restructuring charge similar to the charge likely reflected in fiscal 2023 would indicate that prior acquisitions are not meeting expectations. Such charges are visible in the 10-K/10-Q income statements and goodwill/intangibles footnotes.
- Can Leidos keep converting backlog at a pace that sustains growth if bookings remain below 1.0x in any given quarter?
- How much of the new award mix is fixed-price development versus higher-quality recurring operations and sustainment work?
- Does the DS-4 queue taxonomy meaningfully fit LDOS, or should the canonical mapping stay with DS-3 as the dominant thesis exposure?
- How much of the new bookings flow is fixed-price development versus recurring operations and sustainment work?
- Does the CoreWeave collaboration convert into funded programs in the next 12-18 months, or remain mainly a strategic positioning story?
- Does the Q2 10-Q segment disclosure quantify Land Systems / Dynetics revenue separately, or is it buried in National Security & Digital? (Primary source: 10-Q segment note.)
- Will the "second interceptor" decision (beyond FY2029) force a launcher re-compete that erodes Dynetics' incumbent position?
- Does the ~$943M "held for sale" disposal group include any Land Systems / hardware assets?
Sources:
- FY2025 10-K: sec.gov
- Q2 FY2026 EX-99.1: sec.gov
- X: @ColbyBadhwar (IFPC Inc 2 award), @NatSecLedger (FY2027 budget 96 launchers / FRP timeline), @Defense_Talks, @militaryleakcom
- Does the Q3 FY2026 10-Q / EX-99.1 (~2026-11-03) name the Army cyber follow-on or ACC ISR task order in bookings, or do they remain below disclosure?
- Will IFPC Inc 2 / Enduring Shield / Dynetics appear in Q3 segment commentary now that a named production subcontract exists, or stay at 0 hits?
- Option-exercise rate on the ACC ISR 1+4 structure over FY2027–FY2030?
- Does Q3 FY2026 (~2026-11-03) finally name IFPC production units or the hypersonic TPS/CHGB award in segment commentary, or do they stay below disclosure?
- Navy USV down-select outcome by end of gov FY 2026 — does Leidos convert the maritime-autonomy platform into a program of record?
- VBA RFP (October 2026): does Leidos retain share in the 6-into-1 consolidation, or lose volume to 2–3 surviving vendors?
STRENGTHENED
INTACT — The clearance-and-backlog moat remains durable. The stock is deeply discounted (9.8× P/E, 3.4× backlog/market cap) on a single contract loss that represents <5% of revenue. However, conviction is tempered by low organic growth and the need for new program wins to restore the book-to-bill ratio. The CoreWeave AI partnership adds optionality that the market is not pricing. Monitor Q2 FY2026 earnings for DHA replacement awards and book-to-bill recovery.
STRENGTHENED
INTACT (reinforced with a hardware dimension) — The existing compliance-gated incumbency thesis holds, and this update adds a second, harder moat: Leidos is the incumbent manufacturer of the Army's Enduring Shield missile-defense launcher, locked in via IBCS integration and an FRP ramp with an ~$3.2B IDIQ ceiling. The disconfirming facts (interceptor contestability, no laser upside, small share of backlog) keep this a modifier, not a re-rating catalyst.
INTACT — the $301M Army cyber follow-on and $717M ACC ISR re-award (prime since 2019) are revealed-preference incumbency confirms, and the CW $40M IFPC Inc 2 subcontract is the first production-phase proof on Enduring Shield. None of it moves economic capture or the blended STRONG PROXY (6) cap: 1.19% annualized, ~18% GM, optional ISR ceiling, no 8-K. Hardware remains a durable sole-source overlay on a contestable services base.
INTACT (reaffirmed — hardware franchise thickened). The 09-09 Jefferies fireside and the previously-missed $2.7B hypersonic award materially thicken the defense-tech hardware moat (IFPC 4→8/month, $4B IDIQ, 2.2x defense book-to-bill, maritime autonomy 200k nm). None of it lifts the blended toll-road above STRONG PROXY (6): the dominant economics remain a contestable ~18%-GM government IT/services base, most new awards are IDIQ/option-gated, and health-segment headwinds (MHS GENESIS, VBA) persist. Differentiated scores 8/5/8 re-written to picks_log (third attempt — the 08-29 and 09-05 writebacks never landed).
Sources
21 sources preserved from the latest qualified research update.
- leidos.comsourceOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- data.sec.govdata.sec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- x.comx.comOpen source ↗
- x.comx.comOpen source ↗
- data.sec.govdata.sec.govOpen source ↗
- prnewswire.comprnewswire.comOpen source ↗
- prnewswire.comprnewswire.comOpen source ↗
- uniondemocrat.marketminute.comuniondemocrat.marketminute.comOpen source ↗
- benzinga.combenzinga.comOpen source ↗
- za.investing.comza.investing.comOpen source ↗
- prnewswire.comprnewswire.comOpen source ↗
- stocktitan.netstocktitan.netOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- comptroller.defense.govcomptroller.defense.govOpen source ↗
Leidos (LDOS): Cleared IT Plus the Enduring Shield Hardware Moat
792 words · Research as of 31 Aug 2026
Preserved research context: this long-form synthesis reflects the evidence and valuation snapshot available on 31 Aug 2026. Use the current snapshot above for the latest signal, conviction, target and market-cap values.
Investment Thesis
Leidos is the rare government-IT name with two moats. The first is compliance-gated incumbency: a cleared workforce of roughly 24,255 people (about 77% of ~31,500 employees), a $48.7B backlog with $10.2B funded, and 87% of revenue from U.S. government customers. The second is physical: its Dynetics "Land Systems" unit is the incumbent manufacturer of the U.S. Army's Enduring Shield missile-defense launcher under the IFPC Increment 2 program — a sole-source hardware position locked by IBCS network certification and a 3–5 year re-qualification cycle. The Daily Picks machine holds Leidos as a WATCH in the Digital Sovereignty universe with thesis status INTACT, a toll-road 6 (STRONG PROXY), and differentiated scores of 8/5/8.
The valuation makes the asymmetry explicit: the stock trades at a 9.75x trailing P/E (8.12x forward) with backlog equal to 3.43x market cap — the widest discount in more than five years. Since being flagged in late July, LDOS has already returned +31.14% against a +2.94% benchmark, generating +28.20pp of alpha, and sits 74.9% of the way to its $151.84 target.
Digital Sovereignty / Value-Chain Relevance
Leidos maps to the Defense Software & Mission Systems layer with crossover into defense financial rails and audit. On the services side, the moat is task-order incumbency and accreditation friction: SEC ISS2 (a 10-year, $284M award serving roughly 5,900 users), DISA GSM-O II task orders, NSA TechSIGINT modernization, and MACRO II sit in a portfolio where DoD CMMC cybersecurity compliance phases in through November 2028, raising the cost of displacing incumbents.
The hardware side is the part the IT-services narrative misses. The Enduring Shield launcher fires AIM-9X interceptors against cruise missiles, drones, and rockets, plugs organically into the Army's IBCS "any-sensor/best-shooter" network, and is now in full-rate production. The April 2026 $617M follow-on bought roughly 62 more launchers at about $9.95M each — a revealed-preference signal that the Army declined to pay the 3–5 year re-qualification cost of switching. The IDIQ ceiling of roughly 317 launchers implies up to ~$3.2B of potential revenue, and the FY2027 Army request of 96 launchers alone implies ~$955M. The July 30 CoreWeave collaboration adds a sovereign-AI-cloud vector: Leidos positioning itself as the trusted government AI infrastructure prime.
Catalysts
- Guam deployment: the Army's 3-43 ADA battalion activates October 2026, the first operational fielding of Enduring Shield in a high-priority Indo-Pacific theater.
- Full-rate production ramp: roughly 200 launchers delivered, on order, or requested through FY27, with projections above 300 by FY30.
- Q2 FY2026 results (August 4): revenue $4.548B (+7% YoY), bookings $4.9B, book-to-bill 1.1x, funded backlog +44% YoY; $301M Army cyber and $56.7M Navy mental-health awards surfaced in August.
- CoreWeave partnership converting into funded programs over the next 12–18 months.
- MHS Genesis EHR modernization and TSA credentialing renewals.
Positioning / What the Market May Be Missing
The consensus narrative treats the DHA contract loss as thesis-defining. The research quantifies it as 3–5% of annual revenue against a $48.7B backlog — a sentiment event, not a franchise event. Government-IT incumbents lose and win contracts cyclically; the clearance, workforce, and relationship moat persists across individual programs. What the market is not pricing is the hardware dimension. The Enduring Shield franchise is a physical certification bottleneck on top of the services moat, and the market's IT-services multiple effectively ignores it. At 8.1x forward earnings with a 1.1x book-to-bill and 44% funded-backlog growth, the stock prices pessimism about a business whose backlog is 3.43x its market cap.
Risks and What Invalidates the Thesis
The honest caps: Leidos owns the launcher, not the effector — AIM-9X is procured separately, and the "second interceptor" competition (Boeing/Anduril versus Lockheed Martin/Rafael) could force a launcher architecture change beyond FY2029 that re-competes the Dynetics lock. There is no IFPC-HEL directed-energy upside; the laser branch did not advance to a program of record. Hardware is non-material versus the $48.7B services backlog — it did not merit a mention in the Q2 earnings release — and defense hardware is lower-margin (segment margin fell to 7.0% from 8.4%). The roughly $943M "held for sale" disclosure raises divestiture risk. An insider-sale cluster (Form 4s on August 6 and 13, a Form 144 on August 11) is a watch item. And the services engine faces real hyperscaler substitution at the edges — AWS and Azure federal clouds can contest commodity IT even if they cannot replicate the cleared core.
What to Watch Next
- Q2 FY2026 10-Q segment disclosure quantifying Land Systems / Dynetics revenue.
- Guam activation in October 2026 and launcher production execution through FY27.
- Book-to-bill staying at or above 1.0x.
- CoreWeave collaboration converting into named funded programs.
- Whether the held-for-sale group includes any hardware assets.